WARSAW, Ind., Feb. 28 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. , an independent provider of products to the global orthopedic device industry, announced today that Andrew Miclot, Senior Vice President, Marketing, Sales and Business Development and Investor Relations Officer, is scheduled to present at the Fifth Annual JMP Securities Research Conference on Thursday, March 9th at 3:00 pm PST at The Ritz-Carlton, San Francisco, CA.
A live Web cast of the presentation will be available on Symmetry Medical’s Web site at www.symmetrymedical.com. Presentation slides will be posted on the Web site before the presentation begins. A replay of the Web cast will be available for 90 days after the date of the presentation.
About Symmetry Medical Inc.
Symmetry Medical Inc. is an independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including dental, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.
Forward Looking Statements
Statements in this press release regarding Symmetry Medical Inc.'s business, which are not historical facts may be “forward-looking statements” that involve risks and uncertainties. Forward-looking statements frequently are identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend” and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual results could differ materially from our current expectations. Certain factors that could cause actual results to differ include: the loss of one or more customers; the development of new products or product innovations by our competitors; product liability; changes in management; changes in conditions affecting the economy, orthopedic device manufacturers or the medical device industry generally; and changes in government regulation of medical devices and third-party reimbursement practices. For a discussion of these and other risks and uncertainties that could cause actual results to differ from those contained in the forward-looking statements, we refer you to the Company’s Annual Report filed on Form 10-K, which contains a detailed explanation of the many risk factors as well as the Company’s other filings with the Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. All forward-looking statements are qualified in their entirety by this cautionary statement, and Symmetry Medical Inc. undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.
Investors/Media: The Ruth Group Stephanie Carrington/Jason Rando 646-536-7017/7025 scarrington@theruthgroup.comjrando@theruthgroup.com Contact: Symmetry Medical Inc. Andrew Miclot Senior Vice President Marketing, Sales & Business Development Investor Relations Officer 574-269-7390 ext. 1002
Symmetry Medical Inc.
CONTACT: investors/press, Stephanie Carrington, +1-646-536-7017, orscarrington@theruthgroup.com, or Jason Rando, +1-646-536-7025, orjrando@theruthgroup.com, both of The Ruth Group, for Symmetry Medical Inc.;or Andrew Miclot, Senior Vice President, Marketing, Sales & BusinessDevelopment, Investor Relations Officer of Symmetry Medical Inc.,+1-574-269-7390, ext. 1002
Web site: http://www.symmetrymedical.com//
